中国药理学与毒理学杂志
中國藥理學與毒理學雜誌
중국약이학여독이학잡지
CHINESE JOURNAL OF PHARMACOLOGY AND TOXICOLOGY
2014年
6期
952-956
,共5页
赵颖%穆鑫%阿丽塔%李阳%王昕%唐小利%张永祥%杜冠华
趙穎%穆鑫%阿麗塔%李暘%王昕%唐小利%張永祥%杜冠華
조영%목흠%아려탑%리양%왕흔%당소리%장영상%두관화
药理学%国际发表%学科分布
藥理學%國際髮錶%學科分佈
약이학%국제발표%학과분포
pharmacology%international publication%subject distribution
选择2012版汤森路透科学引证报告自然科学版中药理学源学科222种期刊检索,从学科分类、研究对象和地区、机构分布的角度,通过分析2013年中国药理学工作者在国际学术期刊中发表的论文情况,对我国药理学发展的现状、问题及趋势进行总结与分析。2013年,中国学者参与发表的药理学国际期刊文章共5090篇。学科分布与社会疾病发生率关系密切,基础研究占比重较大,而临床研究水平有待提高。地域、机构分布集中性明显且与科技经费投入密切相关。我国药理学研究已进入快速发展阶段,将继续以威胁人类的重大疾病为重点目标,加强基础与临床药理学研究。
選擇2012版湯森路透科學引證報告自然科學版中藥理學源學科222種期刊檢索,從學科分類、研究對象和地區、機構分佈的角度,通過分析2013年中國藥理學工作者在國際學術期刊中髮錶的論文情況,對我國藥理學髮展的現狀、問題及趨勢進行總結與分析。2013年,中國學者參與髮錶的藥理學國際期刊文章共5090篇。學科分佈與社會疾病髮生率關繫密切,基礎研究佔比重較大,而臨床研究水平有待提高。地域、機構分佈集中性明顯且與科技經費投入密切相關。我國藥理學研究已進入快速髮展階段,將繼續以威脅人類的重大疾病為重點目標,加彊基礎與臨床藥理學研究。
선택2012판탕삼로투과학인증보고자연과학판중약이학원학과222충기간검색,종학과분류、연구대상화지구、궤구분포적각도,통과분석2013년중국약이학공작자재국제학술기간중발표적논문정황,대아국약이학발전적현상、문제급추세진행총결여분석。2013년,중국학자삼여발표적약이학국제기간문장공5090편。학과분포여사회질병발생솔관계밀절,기출연구점비중교대,이림상연구수평유대제고。지역、궤구분포집중성명현차여과기경비투입밀절상관。아국약이학연구이진입쾌속발전계단,장계속이위협인류적중대질병위중점목표,가강기출여림상약이학연구。
To explore the current status, problem and development of pharmacology in China by retrieving articles with Chinese authors published in 222 pharmacology related journals from natural science edition of Journal Citation Reports ( R) 2012, Thomson Reuters. Analysis was conducted based on subjects, research objects, and regional and institutional distribution. The results showed that in 2013 there were totally 5090 articles with Chinese authors published in international journals. The hot research objects were closely related to social incidence of disease. Compared to clinical pharmacology, basic pharmacology has become a priority. The regional and institutional distributions were highly concentrated in regions and institutions that had achieved more scientific funds. Pharmacological research in China has entered an era of accelerating development. The main target pharmacological research will be diseases that pose a serious threat to public health. Basic and clinical pharmacology will be strengthened at the same time.